Regeneron Calls For More Government-Funding of Biologic Manufacturing While Defending High Industry Prices

 
• By Sarah Karlin-Smith
  
Regeneron's George Yancopoulos spoke about COVID-19 and drug pricing on 18 November. • Source: STAT Summit
Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

SpotifyApple PodcastsWebsite

More from Pricing Debate

More from Market Access